Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Over the Counter (OTC) Drugs Market Size study with COVID-19 impact, by Product Type (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight-loss/Dietary Products, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others) and Regional Forecasts 2020-2027

  • BIZ3906386
  • 200 Pages
  • June 2020
  • Healthcare
Download Sample    Get Discount   
 
Global Over the Counter (OTC) Drugs Market is valued approximately USD 266 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6% over the forecast period 2020-2027. Over the Counter (OTC) drugs are also referred as non-prescription medicines, as these can be bought without doctor’s prescriptions. OTC drugs are safe if they are dispensed as per the instructions given by healthcare professionals. OTC drugs are normally regulated according to their active pharmaceutical ingredient (API) instead of final products. By regulating APIs rather than specific drug formulations, government bodies allow manufacturers the autonomy to formulate ingredients, or mixtures of materials, into proprietary combinations. Also, it contains non-nutrient chemicals, which offers biological benefit to the body. Further, the demand for disinfectant products is remarkably growing, as a preventive measure for COVID-19, which has resulted in the rise in demand for OTC drugs & painkillers. That is the short-term impact to market growth. As the production of OTC drugs is less significant due to the lockdown in various countries. Thus, it has forced the companies to develop the post-COVID strategies to avoid decline and promote market growth in the near future. Increasing consumption of dietary supplements, improvement in lifestyle and age-related diseases and growing awareness regarding general health concerns are the few factors responsible for high CAGR of the market over the forecast period. For instance, according to Council for Responsible Nutrition, the U.S.-based trade association, about 76% of Americans of all of all ages are using dietary supplements, an increase of around 64% from 2008. Among all ages, the adults aged 55 & above consume the dietary supplements most, which is about 80% in 2017 increased from 74% since 2016. This, in turn, is expected to accelerate the demand for Over the Counter (OTC) Drugs, thus contributing to the growth of the global market. However, stringent regulatory policies by governing bodies and lack of seamless reclassification of drugs are the few factors expected to hamper the growth of the market over the forecast period of 2020-2027.

The regional analysis of global Over the Counter (OTC) Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the trend among pharmaceutical companies to switch from Rx to OTC drugs and increasing consumption of dietary supplements in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027, due to growing awareness among individuals about the use of OTC drugs to cure minor health issues, especially in China and India.

Major market player included in this report are:

Johnson and Johnson

Novartis AG

Bayer AG

Sanofi

Pfizer

GlaxoSmithKline PLC

Perrigo Company PLC

Reckitt Benckiser Group PLC

Takeda Pharmaceutical Company Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Cough, Cold, and Flu Products

Analgesics

Dermatology Products

Gastrointestinal Products

Vitamins, Mineral, and Supplements (VMS)

Weight-loss/Dietary Products

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacy

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Over the Counter (OTC) Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. Over the Counter (OTC) Drugs Market, by Region, 2018-2027 (USD Billion)

1.2.2. Over the Counter (OTC) Drugs Market, by Product Type, 2018-2027 (USD Billion)

1.2.3. Over the Counter (OTC) Drugs Market, by Distribution Channel, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Over the Counter (OTC) Drugs Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Over the Counter (OTC) Drugs Market Dynamics

3.1. Over the Counter (OTC) Drugs Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Over the Counter (OTC) Drugs Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Over the Counter (OTC) Drugs Market, by Product Type

5.1. Market Snapshot

5.2. Global Over the Counter (OTC) Drugs Market by Product Type, Performance - Potential Analysis

5.3. Global Over the Counter (OTC) Drugs Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)

5.4. Over the Counter (OTC) Drugs Market, Sub Segment Analysis

5.4.1. Cough, Cold, and Flu Products

5.4.2. Analgesics

5.4.3. Dermatology Products

5.4.4. Gastrointestinal Products

5.4.5. Vitamins, Mineral, and Supplements (VMS)

5.4.6. Weight-loss/Dietary Products

5.4.7. Others

Chapter 6. Global Over the Counter (OTC) Drugs Market, by Distribution Channel

6.1. Market Snapshot

6.2. Global Over the Counter (OTC) Drugs Market by Distribution Channel, Performance - Potential Analysis

6.3. Global Over the Counter (OTC) Drugs Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)

6.4. Over the Counter (OTC) Drugs Market, Sub Segment Analysis

6.4.1. Hospital Pharmacies

6.4.2. Retail Pharmacies

6.4.3. Online Pharmacy

6.4.4. Others

Chapter 7. Global Over the Counter (OTC) Drugs Market, Regional Analysis

7.1. Over the Counter (OTC) Drugs Market, Regional Market Snapshot

7.2. North America Over the Counter (OTC) Drugs Market

7.2.1. U.S. Over the Counter (OTC) Drugs Market

7.2.1.1. Product Type breakdown estimates & forecasts, 2017-2027

7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027

7.2.2. Canada Over the Counter (OTC) Drugs Market

7.3. Europe Over the Counter (OTC) Drugs Market Snapshot

7.3.1. U.K. Over the Counter (OTC) Drugs Market

7.3.2. Germany Over the Counter (OTC) Drugs Market

7.3.3. Rest of Europe Over the Counter (OTC) Drugs Market

7.4. Asia-Pacific Over the Counter (OTC) Drugs Market Snapshot

7.4.1. China Over the Counter (OTC) Drugs Market

7.4.2. India Over the Counter (OTC) Drugs Market

7.4.3. Japan Over the Counter (OTC) Drugs Market

7.4.4. Rest of Asia Pacific Over the Counter (OTC) Drugs Market

7.5. Latin America Over the Counter (OTC) Drugs Market Snapshot

7.5.1. Brazil Over the Counter (OTC) Drugs Market

7.5.2. Mexico Over the Counter (OTC) Drugs Market

7.6. Rest of The World Over the Counter (OTC) Drugs Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Johnson and Johnson

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Novartis AG

8.2.3. Bayer AG

8.2.4. Sanofi S.A.

8.2.5. Pfizer Inc.

8.2.6. GlaxoSmithKline PLC

8.2.7. Perrigo Company PLC

8.2.8. Reckitt Benckiser Group PLC

8.2.9. Takeda Pharmaceutical Company Ltd.

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

TABLE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET, REPORT SCOPE

TABLE 2. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)

TABLE 3. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY PRODUCT TYPE 2017-2027 (USD BILLION)

TABLE 4. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2017-2027 (USD BILLION)

TABLE 5. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 6. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 7. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 8. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 9. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 10. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 11. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 12. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 13. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 14. GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 15. U.S. OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 16. U.S. OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 17. U.S. OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 18. CANADA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 19. CANADA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 20. CANADA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 21. UK OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 22. UK OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 23. UK OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 24. GERMANY OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 25. GERMANY OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 26. GERMANY OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 27. ROE OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 28. ROE OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 29. ROE OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 30. CHINA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 31. CHINA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 32. CHINA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 33. INDIA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 34. INDIA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 35. INDIA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 36. JAPAN OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 37. JAPAN OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 38. JAPAN OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 39. ROAPAC OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 40. ROAPAC OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 41. ROAPAC OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 42. BRAZIL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 43. BRAZIL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 44. BRAZIL OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 45. MEXICO OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 46. MEXICO OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 47. MEXICO OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 48. ROLA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 49. ROLA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 50. ROLA OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 51. ROW OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)

TABLE 52. ROW OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 53. ROW OVER THE COUNTER (OTC) DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)

TABLE 54. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET

TABLE 55. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL OVER THE COUNTER (OTC) DRUGS MARKET

TABLE 56. YEARS CONSIDERED FOR THE STUDY

TABLE 57. EXCHANGE RATES CONSIDERED

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research